Dosing chart / Weight & metabolic
AOD-9604 vs HGH Fragment 176-191
Dose, schedule, route and approval status side by side.
Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.
| AOD-9604 | HGH Fragment 176-191 | |
|---|---|---|
| Status | Not approved | Not approved |
| Also known as | hGH fragment 177-191 analog | Frag 176-191 |
| Typical dose | 300 mcg | 250–500 mcg |
| How often | Daily | Daily |
| Schedule | Once daily, usually reported in the morning before food. | Daily, often split into two injections. |
| Daily equivalent | 300 mcg/day | 250–500 mcg/day |
| Route | Subcutaneous | Subcutaneous |
| Duration | 8–12 weeks reported | 8–12 weeks reported |
| Notes | Did not beat placebo for weight loss in its largest human trial (oral dosing). Injected doses are community-reported. | No human efficacy trials. Doses are community-reported. |
This page sets the two chart entries next to each other. It does not say which is better or whether either is right for you. Read member experiences on the AOD-9604 and HGH Fragment 176-191 pages.
Advertisement